Updated EMA-HMA workplan on data and AI in medicines regulation 2026 to 2028

Sexual Safety Signals of Common Antidiabetic Drugs: Insights From FAERS Disproportionality Analysis

US Risk Evaluation and Mitigation Strategies with Elements to Assure Safe Use: A Longitudinal Analysis of REMS Modifications (2008–2022)

Real-World Safety Signals of Drug-Induced Proteinuria: A Two-Decade Pharmacovigilance Study Using Multi-Indicator Detection and Multivariate Correction

Gastrointestinal adverse events associated with tirzepatide: A bibliometric and pharmacovigilance analysis

Safety profile and signal detection of tadalafil: a real-world analysis based on the Food and Drug adverse event reporting system

Assessing Research Impact With Bibliometrics and Altmetrics: The Case of the Canadian Network for Observational Drug Effect Studies (CNODES)

Safety and Effectiveness of Contezolid versus Linezolid in Drug-Resistant Tuberculosis: A 12-Month Retrospective Study from China

Performance-enhancing drug use in sports: a Bayesian variable selection and profile regression approach to identifying risk factors and estimating prevalence

Adverse drug reactions among children with tuberculosis in China: a multicentre study, 2017–2022

Integrating precision medicine and artificial intelligence to prevent cardiotoxicity in cardiovascular drug therapy

EMA recommends restricting use of Tecovirimat SIGA

Efficacy, safety, route of administration of midazolam and diazepam for pediatric status epilepticus: systematic review, meta-analysis, and trial sequential analysis

Patterns of antibiotic-induced cutaneous adverse drug reactions in a tertiary care hospital in India: A retrospective observational study

Safety Profile and Adverse Drug Reactions of Radium-223 in the EudraVigilance Database: A Retrospective Descriptive Analysis

Advancing pharmacoepidemiology and pharmacovigilance: A scoping review of challenges, technological innovations, and global strategies for drug safety

Adverse and Serious Adverse Events Associated With Tocilizumab in COVID-19 Pneumonia and With Cyclosporin, Pazopanib, and Insulin Glargine in Other Diseases: A Single-Center Cross-Sectional Study From a Tertiary Care Center in Bangladesh

International Society of Pharmacovigilance Advances over Time: Strategies and Results of the Advisory Board from 2022 to 2025

Content analysis of illegal online advertisements for hypertension-related drugs and supplements in Taiwan

Risk assessment for cardiovascular adverse drug events in the ICU: Case study on COVID-19 patients

Effectiveness and safety of bedaquiline, pretomanid, linezolid and moxifloxacin in drug-resistant tuberculosis patients in selected public hospitals in Ethiopia: a multicenter retrospective cohort study

Nationwide assessment of community pharmacists’ practices and atorvastatin–drug interactions in Egypt

Boletín sobre Seguridad de Medicamentos de Uso Humano. Enero de 2026

A Qualitative Exploration of the Perspectives on Medication Error Among Healthcare Professionals

Effects of the COVID-19 pandemic on antibiotic use and resistance in French hospitals, 2019–22: a retrospective ecological analysis of national surveillance data